Ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension undergoing sevoflurane anesthesia and spontaneous ventilation

Anesthesia and Analgesia

Volumn 105, Issue 6, 2007, Pages 1578-1584

  Williams, Glyn D ^a   Philip, Bridget M ^a   Chu, Larry F ^a   Boltz, M Gail ^a   Kamra, Komal ^a   Terwey, Heidi ^a   Hammer, Gregory B ^a   Perry, Stanton B ^a   Feinstein, Jeffrey A ^a   Ramamoorthy, Chandra ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BOSENTAN; DIGOXIN; DIURETIC AGENT; KETAMINE; MIDAZOLAM; NITRIC OXIDE; OXYGEN; PROSTACYCLIN; SEVOFLURANE; SILDENAFIL; UNIPROST; WARFARIN;

ADOLESCENT; ARTERIAL PH; ARTERIAL PRESSURE; ARTICLE; BREATHING; CARBON DIOXIDE TENSION; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; DELIRIUM; DIAPHRAGM HERNIA; FACE MASK; FEMALE; GENERAL ANESTHESIA; HEART CATHETERIZATION; HEART INDEX; HEART RATE; HEMODYNAMICS; HUMAN; INFANT; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MEASUREMENT; MINIMUM LUNG ALVEOLUS CONCENTRATION; OPEN STUDY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PEDIATRIC ANESTHESIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE; SYSTEMIC VASCULAR RESISTANCE; VOMITING;

EID: 36549055665     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000287656.29064.89     Document Type: Article

References (37)

1. Galie N, Rubin LJ. Introduction: new insights into a challenging disease. A review of the Third World Symposium on Pulmonary Arterial Hypertension. J Am Coll Cardiol 2003;43:1S
2. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghett M, Rich S, Fishman A. Clinical Classification of Pulmonary Hypertension. J Am Coll Cardiol 2004;43:5S-12S
3. Tulloh R. Management and therapeutic options in pediatric pulmonary hypertension. Expert Rev Cardiovasc Ther 2006;4:361-74
4. Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg 2007;104:521-7
5. Taylor CJ, Derrick G, McEwan A, Haworth SG, Sury MR. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. Br J Anaesth 2007;98:657-61
6. Fischer LG, Van Aken H, Burkle H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg 2003;96:1603-16
7. Blaise G, Langleben D, Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 2003;99:1415-32
8. Petros AJ, Pierce CM. The management of pulmonary hypertension. Pediatr Anesth 2006;16:816-21
9. Heller AR, Litz RJ, Koch T. A fine balance, one-lung ventilation in a patient with Eisenmenger syndrome. Br J Anaesth 2004;92:587-90
10. Yim CF, Lim KS, Low TC. Severe pulmonary hypertension in a patient with bronchiectasis complicated by cor pulmonale and a right-to-left shunt presenting for surgery. Anaesth Intensive Care 2002;30:467-71
11. Kopka A, McMenemin IM, Serpell MG, Quasim I. Anaesthesia for cholecystectomy in two non-parturients with Eisenmenger's syndrome. Acta Anaesthesiol Scand 2004;48:782-6
12. Aye T, Milne B. Ketamine anesthesia for pericardial window in a patient with pericardial tamponade and severe COPD. Can J Anaesth 2002;49:283-6
13. Neema PK, Unnikrishnan M, Sinha PK, Rathod RC. Anesthetic management for a hypertensive patent ductus arteriosus (PDA) closure in a patient with surgically uncorrectable long-segment right pulmonary artery hypoplasia and a ventricular septal defect. J Cardiothorac Vasc Anesth 2003;17:740-3
14. Lyons B, Motherway C, Casey W, Doherty P. The anaesthetic management of the child with Eisenmenger's syndrome. Can J Anaesth 1995;42:904-9
15. Tweed WA, Minuck M, Mymin D. Circulatory responses to ketamine anesthesia. Anesthesiology 1972;37:613-9
16. Spotoft H, Horshin JD, Sorensen MB, Skovsted P. The cardiovascular effects of ketamine for induction of anesthesia in patients with valvular heart disease. Can Anaesth Soc J 1979;26:463-7
17. Berman W, Fripp RR, Rubler M, Alderete L. Hemodynamic effects of ketamine in children undergoing cardiac catheterization. Pediatr Cardiol 1990;11:72-6
18. Wolfe RR, Loehr JP, Schaffer MS, Wiggins JW. Hemodynamic effects of ketamine, hypoxia and hyperoxia in children with surgically treated congenital heart disease residing greater than or equal to 1,200 meters above sea level. Am J Cardiol 1991;67:84-7
19. Morray JP, Lynn AM, Herndon PS, Kawabori, I, Stevenson JG. Hemodynamic effects of ketamine in children with congenital heart disease. Anesth Analg 1984;63:895-9
20. Hickey PR, Hansen DD, Cramolini GM, Vincent RN, Lang P. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1985;62:287-93
21. Oklu E, Bulutcu FS, Yalcin Y, Ozbek U, Cakali E, Bayindir O. Which anesthetic agent alters the hemodynamic status during pediatric catheterization? Comparison of propofol versus ketamine. J Cardiothorac Vasc Anesth 2003;17:686-90
22. Laird TH, Stayer SA, Rivenes SM, Lewin MB, McKenzie ED, Fraser CK, Andropoulos DB. Pulmonary-to-systemic blood flow ratio effects of sevoflurane, isoflurane, halothane, and fentanyl/midazolam with 100% oxygen in children with congenital heart disease. Anesth Analg 2002;95:1200-6
23. Williams GD, Jones TK, Hanson KA, Morray JP. The hemodynamic effects of propofol in children with congenital heart disease. Anesth Analg 1999;89:1411-6
24. Bovill JG. Intravenous anesthesia for the patient with left ventricular dysfunction. Semin Cardiothorac Vasc Anesth 2006;10:43-8
25. Friesen RH, Alswang M. Changes in carbon dioxide tension and oxygen saturation during deep sedation for paediatric cardiac catheterization. Paediatr Anaesth 1996;6:15-20
26. Burrows FA, Klinck JR, Rabinovitch M, Bohn DJ. Pulmonary hypertension in children: perioperative management. Can Anaesth Soc J 1986;33:606-28
27. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S. Diagnosis and differential assessment of pulmonary arterial hypertension. Am Coll Cardiol 2004;43:40S-47S
28. White PF, Way WL, Trevor AJ. Ketamine - its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36
29. Rich GF, Roos CM, Anderson SM, Daugherty MO, Uncles DR. Direct effects of intravenous anesthetics on pulmonary vascular resistance in the isolated rat lung. Anesth Analg 1994;78:961-6
30. Akata T, Izumi K, Nakashima M. Mechanisms of direct inhibitory action of ketamine on vascular smooth muscle in mesenteric resistance arteries. Anesthesiology 2001;95:452-62
31. Lee TS, Hou X. Vasoactive effects of ketamine on isolated rabbit pulmonary arteries. Chest 1995;107:1152-5
32. Maruyama K, Maruyama J, Yokochi A, Muneyuki M, Miyasaka K. Vasodilatory effects of ketamine on pulmonary arteries in rats with chronic hypoxic pulmonary hypertension. Anesth Analg 1995;80:786-92
33. Kaye AD, Banister RE, Fox CJ, Ibrahim IN, Nossaman BD. Analysis of ketamine responses in the pulmonary vascular bed of the cat. Crit Care Med 2000;28:1077-82
34. Abdalla SS, Laravuso RB, Will JA. Mechanisms of the inhibitory effect of ketamine on guinea pig isolated main pulmonary artery. Anesth Analg 1994;78:17-22
35. Miyawaki I, Nakamura K, Terasako K, Toda H, Kakuyama M, Mori K. Modification of endothelium-dependent relaxation by propofol, ketamine, and midazolam. Anesth Analg 1995;81:474-9
36. Ogawa K, Tanaka S, Murray PA. Inhibitory effects of etomidate and ketamine on endothelium-dependent relaxation in canine pulmonary artery. Anesthesiology 2001;94:668-77
37. Rees DI, Gaines GY. One-lung ventilation - a comparison of pulmonary gas exchange during anesthesia with ketamine or enflurane. Anesth Analg 1984;63:521-5